Literature DB >> 7136865

Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases.

H Magdelenat, B F Pertuiset, M Poisson, P M Martin, J Philippon, B Pertuiset, A Buge.   

Abstract

Progestin receptors (PR) were evaluated in 40 intracranial and 2 spinal meningiomas. PR measured with radiolabelled R 5020 were found in 93% of cases (39/42). PR levels were significantly higher (p = 0.05) in females (mean: 5,720 fmol/gmT) than in males (mean: 3,120 fmol/gmT). Biochemical characterization of the R 5020 saturable binding sites showed that they were mainly cytosolic, had a high affinity constant (Kd approximately equal to 1 nM) and were progestin specific. Correlation with sex suggested some biological activity of PR in meningiomas. Oestrogen receptors (OR) were evaluated in 36 intracranial and 2 spinal meningiomas. OR measured with radiolabelled R 2858 were present in 79% of cases (30/38). OR mean levels were equal in females (mean: 285 fmol/gmT) and in males (mean: 330 fmol/gmT). The relevance of PR and possibly OR in the biology of meningiomas and of leptomeninges was suggested by the presence of receptors in a sample of normal leptomeninges.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7136865     DOI: 10.1007/bf01406053

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  25 in total

1.  The relapsing course of certain meningiomas in relation to pregnancy and menstruation.

Authors:  E R BICKERSTAFF; J M SMALL; I A GUEST
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-05       Impact factor: 10.154

2.  Mero-receptors: proteolytic fragments of receptors containing the steroid-binding site.

Authors:  M R Sherman; L A Pickering; F M Rollwagen; L K Miller
Journal:  Fed Proc       Date:  1978-02

3.  Effect of calcium on chick thymus glucocorticoid receptor.

Authors:  P Arányi; A Náray
Journal:  J Steroid Biochem       Date:  1980-01       Impact factor: 4.292

4.  Histological subtypes and prognostic problems in meningiomas.

Authors:  K Jellinger; F Slowik
Journal:  J Neurol       Date:  1975       Impact factor: 4.849

5.  Steroid hormone receptors and disease: breast cancer.

Authors:  W L McGuire
Journal:  Proc Soc Exp Biol Med       Date:  1979-10

6.  11beta-Methoxy-17-ethynyl-1,3,5(10)-estratriene-3,17beta-diol (moxestrol), a tag for estrogen receptor binding sites in human tissues.

Authors:  J P Raynaud; P M Martin; M M Bouton; T Ojasoo
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

7.  Estrogen-receptor protein in intracranial meningiomas.

Authors:  M S Donnell; G A Meyer; W L Donegan
Journal:  J Neurosurg       Date:  1979-04       Impact factor: 5.115

8.  Estrogen receptor proteins in diverse human tumors.

Authors:  K E Stedman; G E Moore; R T Morgan
Journal:  Arch Surg       Date:  1980-03

9.  A study of glucocorticoid receptors in intracranial tumors.

Authors:  Z Y Yu; O Wrange; J Boëthius; A Hatam; L Granholm; J A Gustafsson
Journal:  J Neurosurg       Date:  1981-11       Impact factor: 5.115

10.  Oestrogen receptors in human malignant melanoma.

Authors:  R I Fisher; J P Neifeld; M E Lippman
Journal:  Lancet       Date:  1976-08-14       Impact factor: 79.321

View more
  17 in total

1.  Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages--immunohistochemical study of 107 cases.

Authors:  J D Jacquemier; J Hassoun; M Torrente; P M Martin
Journal:  Breast Cancer Res Treat       Date:  1990-02       Impact factor: 4.872

2.  Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma.

Authors:  S M Grunberg; M H Weiss
Journal:  J Neurooncol       Date:  1990-02       Impact factor: 4.130

3.  Steroid receptor status difference in recurrent intracranial meningioma and breast cancer in the same patient.

Authors:  H Magdelenat; B F Pertuiset; M Poisson; J Philippon
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

4.  The effect of prolactin and bombesin on the growth of meningioma-derived cells in monolayer culture.

Authors:  E Jimenez-Hakim; M el-Azouzi; P M Black
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

5.  Steroid hormone receptors in human meningiomas, gliomas and brain metastases.

Authors:  M Poisson; B F Pertuiset; J J Hauw; J Philippon; A Buge; M Moguilewsky; D Philibert
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

Review 6.  Chemotherapy for meningiomas.

Authors:  A P Kyritsis
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

7.  Correlations of female steroid hormone receptors with histologic features in meningiomas.

Authors:  J Piquer; M Cerda; A Lluch; J L Barcia Salorio; J Garcia-Conde
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

8.  The prognostic value of progesterone receptor status in meningiomas.

Authors:  F Roser; M Nakamura; M Bellinzona; S K Rosahl; H Ostertag; M Samii
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

Review 9.  Treatment of meningioma: an update.

Authors:  Anthony L D'Ambrosio; Jeffrey N Bruce
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

10.  Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases.

Authors:  J Jääskeläinen; E Laasonen; J Kärkkäinen; M Haltia; H Troupp
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.